Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroimmune contributions to Alzheimer’s disease: a focus on human data
Verena Haage, Philip L. De Jager
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3164-3181
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Inflammatory aspects of Alzheimer’s disease
Pablo Botella Lucena, Michael T. Heneka
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 23
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, et al.
Cell Reports (2025), pp. 115109-115109
Open Access | Times Cited: 8
Clonal hematopoiesis, somatic mosaicism, and age-associated disease
Megan A. Evans, Kenneth Walsh
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 649-716
Open Access | Times Cited: 49
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease
Carlos Cruchaga, Daniel Western, Jigyasha Timsina, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 26
Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD
Svetlana Ukraintseva, Arseniy Yashkin, Igor Akushevich, et al.
Experimental Gerontology (2024) Vol. 190, pp. 112411-112411
Open Access | Times Cited: 12
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
Daniel Western, Jigyasha Timsina, Lihua Wang, et al.
Nature Genetics (2024) Vol. 56, Iss. 12, pp. 2672-2684
Open Access | Times Cited: 9
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Rashi I. Mehta, Rupal I. Mehta
Biomedicines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 21
“Brain‐IT”: Exergame training with biofeedback breathing in neurocognitive disorders
Patrick Manser, Eling D. de Bruin
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4747-4764
Open Access | Times Cited: 7
Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification
Huan Zhong, Xiaopu Zhou, Hyebin Uhm, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2469-2484
Open Access | Times Cited: 6
The toxic metal hypothesis for neurological disorders
Roger Pamphlett, David Bishop
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 16
Sepsis exacerbates Alzheimer’s disease pathophysiology, modulates the gut microbiome, increases neuroinflammation and amyloid burden
Vijayasree V. Giridharan, Celso S. G. Catumbela, Carlos Henrique Rocha Catalão, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4463-4473
Open Access | Times Cited: 15
Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
Ajay Kumar Nair, Carol A. Van Hulle, Barbara B. Bendlin, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 13
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer’s disease
L. Meng, Han Jin, Burak Yuluğ, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Diana Boraschi, Paola Italiani, Paola Migliorini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research
Alberto Granzotto, Bryce Vissel, Stefano L. Sensi
eLife (2024) Vol. 13
Open Access | Times Cited: 4
Pharmacological Evaluation of Aescin for Neuroprotection in Intracerebroventricular Streptozotocin Model of Alzheimer’s Disease in Experimental Rats
Shaveta Bhardwaj, Anu Jindal, Shamsher Singh, et al.
Assay and Drug Development Technologies (2025)
Closed Access
The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology
Mai M. Anwar
Ibrain (2023) Vol. 9, Iss. 1, pp. 63-71
Open Access | Times Cited: 10
Implication of tau propagation on neurodegeneration in Alzheimer’s disease
Daniel Lamontagne-Kam, Anosha Kiran Ulfat, Vincent Hervé, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer’s Disease
Mai Yamakawa, Jessica E. Rexach
Biomedicines (2024) Vol. 12, Iss. 2, pp. 308-308
Open Access | Times Cited: 3
Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer’s disease
Qiang Li, Bing Li, Li Liu, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Multi-enzyme mimic nanozyme with enhanced catalysis for methylene blue probe promotes the one-step detection of tau protein
Xiyu Chen, Shuo Yang, Huikai Shao, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155897-155897
Closed Access | Times Cited: 3
CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti‐tau antibody semorinemab
Cosme Sandoval, Julie Lee, Balázs I. Tóth, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 7940-7953
Open Access | Times Cited: 3
Identification of immunogenic cell death-related genes involved in Alzheimer’s disease
Rui Wang, Yaming Du, Wei Shao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer’s disease
Francesca Bernocchi, Chiara Giuseppina Bonomi, Martina Assogna, et al.
Neurobiology of Aging (2024) Vol. 141, pp. 66-73
Open Access | Times Cited: 2
The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s Disease
Xianbo Zhuang, Lin Jie, Yamin Song, et al.
NeuroMolecular Medicine (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top